子宫肌瘤剔除术相关的输血风险及术后并发症
这项回顾性队列研究纳入3407例子宫症状性肌瘤行肌瘤剔除术的女性,评估输血风险及术后30天并发症。总体输血率为10%(宫腔镜6.7%、腹腔镜2.7%、开腹16.4%),独立危险因素包括黑人种族、术前红细胞压积<30%、术前输血、高肌瘤负荷、手术时间长及开腹途径;调整混杂后需输血者发生主要术后并发症的风险约增加三倍(aOR 2.69,95%CI 1.58-4.57)。
要点
- 肌瘤剔除术总体输血率为10%,开腹手术输血率16.4%高于腹腔镜2.7%和宫腔镜6.7%。
- 术前红细胞压积<30%者输血风险显著升高(aOR 6.41,95%CI 4.45-9.23)。
- 调整混杂因素后,需要输血者发生主要术后并发症的风险约增加三倍(aOR 2.69,95%CI 1.58-4.57)。
核心结论
- 大型多中心数据库分析提示,肌瘤剔除术总体输血风险为10%,且与术后30天并发症增加相关。
- 作者认为,术前筛查输血高风险女性是审慎的,因为围手术期输血本身会导致主要术后并发症增加。
研究设计与样本
- 回顾性队列研究,纳入3407例因症状性子宫肌瘤行肌瘤剔除术的女性。
- 干预为肌瘤剔除术中或术后72小时内输血;主要结局为输血率及输血相关危险因素,次要结局为术后30天并发症。
主要发现
- 总体输血率为10%,其中宫腔镜6.7%、腹腔镜2.7%、开腹手术16.4%。
- 与白人相比,黑人种族输血风险升高(aOR 2.27,95%CI 1.62-3.17),其他种族亦升高(aOR 1.77,95%CI 1.20-2.63)。
- 术前红细胞压积<30%较≥30%者输血风险升高(aOR 6.41,95%CI 4.45-9.23);术前输血者风险升高(aOR 2.81,95%CI 1.46-5.40)。
- 高肌瘤负荷者输血风险升高(aOR 1.91,95%CI 1.45-2.51);手术时间第四四分位较第一四分位者风险升高(aOR 11.55,95%CI 7.05-18.93)。
- 开腹途径较腹腔镜途径输血风险升高(aOR 9.06,95%CI 6.10-13.47);调整混杂后,需输血者发生主要术后并发症的风险约增加三倍(aOR 2.69,95%CI 1.58-4.57)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate blood transfusion risks and the associated 30-day postoperative morbidity after myomectomy. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): Women who underwent myomectomies for symptomatic uterine fibroids (N = 3,407). INTERVENTION(S): Blood transfusion during or within 72 hours after myomectomy. MAIN OUTCOME MEASURE(S): The primary outcomes were rate of blood transfusion with myomectomy and risk factors associated with receiving a transfusion. The secondary outcome was 30-day morbidity after myomectomy. RESULT(S): The overall rate of blood transfusion was 10% (hysteroscopy, 6.7%; laparoscopy, 2.7%; open/abdominal procedures, 16.4%). Independent risk factors for transfusion included as follows: black race (adjusted odds ratio [aOR] 2.27, 95% confidence interval [CI] 1.62-3.17) and other race (aOR 1.77, 95% CI 1.20-2.63) compared with white race; preoperative hematocrit <30% compared to ≥30% (aOR 6.41, 95% CI 4.45-9.23); preoperative blood transfusion (aOR 2.81, 95% CI 1.46-5.40); high fibroid burden (aOR 1.91, 95% CI 1.45-2.51); prolonged surgical time (fourth quartile vs. first quartile aOR 11.55, 95% CI 7.05-18.93); and open/abdominal approach (open/abdominal vs. laparoscopic aOR 9.06, 95% CI 6.10-13.47). Even after adjusting for confounders, women who required blood transfusions had an approximately threefold increased risk for experiencing a major postoperative complication (aOR 2.69, 95% CI 1.58-4.57). CONCLUSION(S): Analysis of a large multicenter database suggests that the overall risk of blood transfusion with myomectomy is 10% and is associated with an increased 30-day postoperative morbidity. Preoperative screening of women at high risk for transfusion is prudent as perioperative transfusion itself leads to increased major postoperative complications.
引用
- Kim T, Purdy MP, Kendall-Rauchfuss L, et al. Myomectomy associated blood transfusion risk and morbidity after surgery. Fertil Steril. 2020. PMID: 32532486. doi:10.1016/j.fertnstert.2020.02.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。